The Department of Health and Human Services and the Department of Veterans Affairs have developed a demonstration of the standards to permit sensitive health information to be shared responsibly among providers using electronic health records, while abiding by confidentiality rules and guidelines.
The U.S. House of Representatives Energy and Commerce Committee has approved H.R. 1206, the Access to Professional Health Insurance Advisors Act, with a 26-14 vote.
The Immunoglobulin Nursing Society (IgNS) held its first national conference in Orlando, Fla., August 3 through 5.
Baxter International has received U.S. Food and Drug Administration approval for a 4,000 IU dosage of Advate (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free Method).
Beginning in 2014, nearly six million U.S. citizens are expected to purchase health insurance or face an average tax penalty of $1,200, following a Supreme Court 5-4 decision this past summer that upheld the constitutionality of the Affordable Care Act.
The U.S. House of Representatives has introduced a bill that intends to clarify and shorten the U.S. Food and Drug Administration’s assessment process of mobile health apps.
A new study shows that children whose mothers had the flu or ran a fever lasting more than a week during pregnancy had an increased risk of developing an autism spectrum disorder.
In a recent study, scientists found that high doses of niacin, or vitamin B3, massively boost the body’s defenses against staphylococcus bacteria.
Despite only 29 human cases of the new strain of swine flu in the past two years, the Centers for Disease Control and Prevention (CDC) is preparing an H3N2 candidate vaccine, and clinical trials are being planned for this year.
Researchers at the University ofBritish Columbia (UBC) have found that the swine flu vaccine triggers antibodies that protect against many flu viruses, including the lethal bird flu strain.
Researchers in a university hospital sought to determine the spectrum of clinical manifestations, immunological characteristics and the time to diagnose patients with common variable immunodeficiency disorders.
New research suggests it might someday be possible to create a vaccine that could protect a growing fetus from premature birth and related complications.